On Tuesday, Ocugen Inc (NASDAQ: OCGN) opened lower -3.60% from the last session, before settling in for the closing price of $1.11. Price fluctuations for OCGN have ranged from $0.51 to $1.98 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 32.82% annually for the last half of the decade. Company’s average yearly earnings per share was noted -10.00% at the time writing. With a float of $286.77 million, this company’s outstanding shares have now reached $292.03 million.
In an organization with 95 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 100.0%, operating margin of -1261.43%, and the pretax margin is -1271.12%.
Ocugen Inc (OCGN) Insider Updates
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Ocugen Inc is 1.80%, while institutional ownership is 26.32%. The most recent insider transaction that took place on Jul 09 ’25, was worth 122,887. Before that another transaction happened on Jun 11 ’25, when Company’s Director proposed sale 146,705 for $1.17, making the entire transaction worth $171,029.
Ocugen Inc (OCGN) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around -10.00% per share during the next fiscal year.
Ocugen Inc (NASDAQ: OCGN) Trading Performance Indicators
Check out the current performance indicators for Ocugen Inc (OCGN). In the past quarter, the stock posted a quick ratio of 2.60. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 69.13.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.19, a number that is poised to hit -0.06 in the next quarter and is forecasted to reach -0.24 in one year’s time.
Technical Analysis of Ocugen Inc (OCGN)
Let’s dig in a bit further. During the last 5-days, its volume was 4.5 million. That was inferior than the volume of 4.85 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 70.97%.
During the past 100 days, Ocugen Inc’s (OCGN) raw stochastic average was set at 71.61%, which indicates a significant increase from 58.20% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0737 in the past 14 days, which was higher than the 0.0696 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.9352, while its 200-day Moving Average is $0.8298. However, in the short run, Ocugen Inc’s stock first resistance to watch stands at $1.1333. Second resistance stands at $1.1967. The third major resistance level sits at $1.2333. If the price goes on to break the first support level at $1.0333, it is likely to go to the next support level at $0.9967. Assuming the price breaks the second support level, the third support level stands at $0.9333.
Ocugen Inc (NASDAQ: OCGN) Key Stats
There are currently 292,031K shares outstanding in the company with a market cap of 312.47 million. Presently, the company’s annual sales total 4,060 K according to its annual income of -54,050 K. Last quarter, the company’s sales amounted to 1,480 K and its income totaled -15,350 K.
